Paediatric and neonatal sepsis and inflammation

E J Molloy1,2,3,4,5, C F Bearer6,7

  • 1Paediatrics, Trinity College Dublin, Trinity Research in Childhood Centre (TRiCC), Dublin, Ireland. Eleanor.molloy@tcd.ie.

Pediatric Research
|January 20, 2022
PubMed

Insights

Sepsis significantly impacts global child mortality, particularly in neonates. Improving early recognition, diagnosis, and management is crucial for better outcomes in pediatric sepsis.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Neonatology

Background:

  • Sepsis is a leading cause of child mortality globally, with high incidence in neonates (3 million cases annually).
  • Neonatal sepsis carries a significant mortality rate of 11-19% and potential long-term neurodevelopmental consequences.
  • Current challenges include early recognition, diagnosis, and standardized management protocols for pediatric sepsis.

Discussion:

  • Review of diagnostic criteria for pediatric sepsis and inflammation.
  • Exploration of current and novel biomarkers for sepsis detection in children.
  • Analysis of management strategies and their effectiveness in pediatric sepsis cases.

Key Insights:

  • Early and accurate diagnosis of sepsis in children remains a significant clinical challenge.
  • Standardized management protocols are needed to reduce mortality and morbidity.
  • Neurodevelopmental outcomes in pediatric sepsis survivors require further quantification.

Outlook:

  • Future strategies focus on improving diagnostic accuracy and timely intervention.
  • Development of novel biomarkers for enhanced sepsis detection in pediatric populations.
  • Need for global collaboration to address the burden of pediatric sepsis and improve patient outcomes.